B. Metzler seel. Sohn & Co’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.45M Sell
29,725
-246
-0.8% -$45.3K 0.05% 205
2025
Q4
$5.27M Buy
29,971
+17,489
+140% +$2.86M 0.05% 205
2025
Q3
$1.75M Hold
12,482
0.02% 422
2025
Q2
$1.57M Hold
12,482
0.02% 435
2025
Q1
$1.71M Buy
12,482
+2,354
+23% +$337K 0.02% 389
2024
Q4
$1.55M Buy
10,128
+2,767
+38% +$467K 0.02% 438
2024
Q3
$1.43M Buy
7,361
+1,500
+26% +$314K 0.01% 467
2024
Q2
$1.36M Buy
5,861
+141
+2% +$30.6K 0.01% 459
2024
Q1
$1.23M Sell
5,720
-729
-11% -$171K 0.01% 478
2023
Q4
$1.67M Sell
6,449
-2,199
-25% -$540K 0.02% 400
2023
Q3
$2.22M Buy
8,648
+1,960
+29% +$524K 0.03% 301
2023
Q2
$1.91M Buy
6,688
+38
+0.6% +$11.3K 0.03% 382
2023
Q1
$1.85M Sell
6,650
-1,086
-14% -$300K 0.03% 325
2022
Q4
$2.14M Buy
7,736
+797
+11% +$225K 0.04% 276
2022
Q3
$1.85M Sell
6,939
-3,709
-35% -$788K 0.03% 304
2022
Q2
$2.17M Sell
10,648
-131
-1% -$26.8K 0.04% 275
2022
Q1
$2.27M Buy
10,779
+584
+6% +$127K 0.03% 309
2021
Q4
$2.45M Buy
10,195
+841
+9% +$216K 0.03% 291
2021
Q3
$2.65M Sell
9,354
-1,526
-14% -$500K 0.04% 258
2021
Q2
$3.77M Sell
10,880
-5,193
-32% -$1.57M 0.06% 192
2021
Q1
$4.5M Sell
16,073
-1,760
-10% -$475K 0.07% 161
2020
Q4
$4.51M Buy
+17,833
New +$4.6M 0.08% 146

Other funds holding BIIB

B. Metzler seel. Sohn & Co's BIIB Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co reduced its Biogen (BIIB) stake by 0.82% in Q1 2026, selling an estimated $45.3K and leaving 29,725 shares worth $5.45M. The position accounts for 0.05% of the portfolio, ranked #205.

B. Metzler seel. Sohn & Co first reported a position in BIIB in Q4 2020 and has held it in 22 quarters since. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 29,725 shares of Biogen worth $5.45M as of Q1 2026.
  • B. Metzler seel. Sohn & Co sold 246 Biogen shares in Q1 2026, an estimated $45.3K.
  • Biogen made up 0.05% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #205 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Biogen in Q4 2020 and has held it in 22 quarters since.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.